Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Castle Biosciences Inc CSTL

Healthcare
Castle Biosciences, Inc. is a commercial-stage diagnostics company. The Company is focused on providing physicians and their patients with personalized, clinically actionable information to clinicians and their patients to inform treatment decisions and improve health outcomes. Its portfolio consists of tests for skin cancers, uveal melanoma, Barretts esophagus and mental health conditions. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CSTL)

DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck

Business Wire 1 day ago

Castle Biosciences Reports First Quarter 2024 Results

Business Wire 2 days ago

Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood's Designation as a Sun Safe Leadership Model City by IMPACT Melanoma

Business Wire 4 days ago

Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024

Business Wire April 11, 2024

Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations

Business Wire April 10, 2024

Castle Biosciences' Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year

Business Wire April 10, 2024

Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer

Business Wire April 4, 2024

Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Business Wire April 2, 2024

Castle Biosciences Announces Updates to its Board of Directors

Business Wire March 27, 2024
View More News ››

Opinion & Analysis (NDAQ:CSTL)

Castle Biosciences Shares Storm Higher After Quadrupling Q3 YoY Revenue

Streetwise Reports November 13, 2019
View More Opinion ››

Bullboard Posts (NDAQ:CSTL)

Study Finds DecisionDx&#xAE;-Melanoma Significantly Improves

Breaking News: $CSTL Study Finds DecisionDx&#xAE;-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I...
whytestocks - February 26, 2024
View more Bullboard ››

Shiny Health & Wellness Corp.

Shiny Health & Wellness Corp.

Shiny Health & Wellness Corp. is on a mission to help people never settle, live fully by being a trusted source for health ...
View More »